1. Home
  2. VERA vs ENVA Comparison

VERA vs ENVA Comparison

Compare VERA & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ENVA
  • Stock Information
  • Founded
  • VERA 2016
  • ENVA 2011
  • Country
  • VERA United States
  • ENVA United States
  • Employees
  • VERA N/A
  • ENVA N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • VERA Health Care
  • ENVA Finance
  • Exchange
  • VERA Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • VERA 2.5B
  • ENVA 2.2B
  • IPO Year
  • VERA 2021
  • ENVA N/A
  • Fundamental
  • Price
  • VERA $46.26
  • ENVA $100.29
  • Analyst Decision
  • VERA Strong Buy
  • ENVA Buy
  • Analyst Count
  • VERA 9
  • ENVA 7
  • Target Price
  • VERA $54.33
  • ENVA $88.00
  • AVG Volume (30 Days)
  • VERA 1.1M
  • ENVA 261.8K
  • Earning Date
  • VERA 11-07-2024
  • ENVA 10-22-2024
  • Dividend Yield
  • VERA N/A
  • ENVA N/A
  • EPS Growth
  • VERA N/A
  • ENVA 5.61
  • EPS
  • VERA N/A
  • ENVA 6.23
  • Revenue
  • VERA N/A
  • ENVA $1,170,788,000.00
  • Revenue This Year
  • VERA N/A
  • ENVA N/A
  • Revenue Next Year
  • VERA N/A
  • ENVA $17.77
  • P/E Ratio
  • VERA N/A
  • ENVA $16.13
  • Revenue Growth
  • VERA N/A
  • ENVA 14.80
  • 52 Week Low
  • VERA $12.28
  • ENVA $39.59
  • 52 Week High
  • VERA $51.61
  • ENVA $106.51
  • Technical
  • Relative Strength Index (RSI)
  • VERA 54.02
  • ENVA 67.65
  • Support Level
  • VERA $47.16
  • ENVA $100.65
  • Resistance Level
  • VERA $51.61
  • ENVA $106.51
  • Average True Range (ATR)
  • VERA 2.99
  • ENVA 2.58
  • MACD
  • VERA 0.21
  • ENVA 0.81
  • Stochastic Oscillator
  • VERA 52.82
  • ENVA 74.19

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and the United Kingdom. Consumers apply for credit online, receive a decision almost immediately, and can receive funds within one day. Enova acts as either the lender or a third-party facilitator between borrowers and other lenders. The company earns revenue from interest income, finance charges, and other fees, including fees on the transactions between borrowers and third-party lenders. The majority of revenue comes from the United States. The company realizes similar amounts of revenue from each of its three different products: short-term loans, lines of credit, and installment loans.

Share on Social Networks: